April 22 (Reuters) - LabCorp said on Wednesday it would expand serological testing for the new coronavirus to more hospitals and healthcare organizations.
Physicians will be able to direct patients not showing COVID-19 symptoms to LabCorp’s approximately 2,000 patient service centers for specimen collection for the antibody tests starting April 27, the company said.
The tests, which aim to identify individuals who have been exposed to the virus by detecting the presence of antibodies to the virus, are in addition to LabCorp’s existing molecular test for COVID-19 that is already available nationwide through healthcare providers, the company said. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Vinay Dwivedi)
Our Standards: The Thomson Reuters Trust Principles.